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The understanding of the structure and function of cGMP-dependent protein kinase (cGMP kinase) has been hindered by the difficulty to obtain 
large quantities of functional enzyme. A recombinant baculovirus encoding bovine cGMP kinase Ia was constructed and purified. Infected insect 
cells synthesized large amounts of soluble and biologically active cGMP kinase Ia representing up to 10% of the total cell extract protein. The 
recombinant enzyme had an identical apparent molecular mass, cGMP affinity and kinase activity as the native bovine lung enzyme. The high-level 
expression of functional cGMP kinase Ia should provide an excellent ool to study further the structure and function of cGMP kinase. 
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1. INTRODUCTION 
Serine/threonine protein kinases are involved in sig- 
nal transducing pathways and play an important role in 
the regulation of eukaryotic cell functions [l]. Cyclic 
GMP-dependent protein kinase (cGMP kinase) is a 
member of this large protein kinase family [24]. Two 
types of cGMP kinase have been identified and cloned 
from mammalian tissues [5-71. The bovine type I en- 
zyme is a homodimer of 75 kDa subunits and is present 
at low concentrations in most tissues. Traditional puri- 
fication of the enzyme is difficult and tedious. This has 
hampered detailed biochemical and functional studies. 
the generation of milligramme amounts of biologically 
active bovine cGMP kinase Ia using the baculovirusl 
insect cell system, thus overcoming the problems inher- 
ent to mammalian and bacterial expression systems. 
2. MATERIALS AND METHODS 
2.1. Cells and virus 
Biologically active enzyme could be expressed in 
mammalian cell lines [8,9], but only at low levels, e.g. 
up to 0.5% of the soluble cell protein in transiently 
transfected COS cells [8]. Bacterial expression of cGMP 
kinase led to the synthesis of large amounts of cGMP 
kinase reaching about 30% of the total cell protein [lo]. 
However, the recombinant protein was catalytically in- 
active and mainly present in, an insoluble form, which 
could not be refolded to a functional enzyme [lo]. 
Standard methods of gene expression using the baculovirus/insect 
cell system were used as described by O’Reilly et al. [12]. Spodoptera 
frugiperda (SD) cells were propagated as a monolayer culture at 27°C 
in TC 100 insect medium (Biochrom) supplemented with 10% fetal calf 
serum (Biochrom), 4 mM L-glutamine, 100 IUlml penicillin and 100 
&ml streptomycin. Suspension cultures were grown in the same me- 
dium additionally supplemented with 1 x lipid concentrate (Gibcol 
BRL) and 0.1% pluronic F-68 (Gibco/BRL) at 27°C in 2 liter Erlen- 
meyer flasks on a rotary shaker at 100 rounds per minute. Total cell 
density was measured with a hemocytometer and viability determined 
by Trypan blue dye exclusion. Recombinant Autographa calijiornica 
nuclear polyhedrosis virus (AcNPV) was propagated using monolayer 
cultures of St9 cells and titered by end-point dilution. Viral infections 
were generally carried out at a multiplicity of infection (MOI) of 1. 
2.2. Construction and purification of recombinant virus 
Recently, expression of recombinant proteins in in- 
sect cells using vectors based on a baculovirus has 
emerged as an efficient method for the high-level expres- 
sion of biologically active eukaryotic proteins [11,12]. 
This expression system has been used successfully for 
the overexpression of several serine/threonine protein 
kinases [12-151. However, like in other expression sys- 
tems, levels of recombinant proteins may vary substan- 
tially (by factor of 500) and synthesis of a fully func- 
tional protein is not guaranteed [12,16]. Here we report 
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Molecular biology techniques were performed according to Sam- 
brook et al. [17]. A 2.1 kb EcoRI-EcoRI cDNA fragment, coding for 
bovine cGMP kinase Ia, was excised from plasmid p91023Ia [8] and 
ligated into the EcoRI restriction site of baculovirus transfer vector 
pVL1393 [12]. The cGMP kinase coding sequence was properly orien- 
tated for transcription from the polyhedrin promotor. The translation 
initiation context was ccaaaaacATGAGCGAG starting at the last 
residue of the EcoRI restriction site. The cGMP kinase encoding 
sequence is indicated by capital letters and a stop codon is underlined, 
which was in frame with the mutated upstream polyhedrin start codon. 
The ligation mixture was electroporated into Escherichia coli DH5a 
and correct transformants were identified by PCR colony screening, 
restriction analysis of the plasmid DNA and dideoxy sequencing of 
the manipulated regions. The recombinant ransfer vector pVLl3931 
acgk contained nucleotides (nt) -6 to 2119 of the bovine cGMP kinase 
Ia cDNA [5] including the entire coding sequence (nt l-2013). 
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Recombinant baculovirus was prepared by co-transfection of Bacu- 
loGold baculovirus DNA (Pharmingen) (50 ng) and anion-exchange- 
purified transfer vector pVL1393/acgk (500 ng) into St9 cells using the 
liposome-mediated method [12]. Recombinant virus was isolated by 
plaque purification and was subsequently used to infect Sf9 monolayer 
cultures. Two days post-infection (pi.) cells and supematants were 
harvested and analyzed for expression of cGMP kinase Ia by im- 
munoblotting, by binding of cGMP and by the phosphotransferase 
reaction. High titer stocks of recombinant virus (lo7 to 10’ plaque- 
forming units/ml) were obtained after three amplification steps using 
St9 monolayer cultures and were stored at 4°C. 
2.3. Expression of cGMP kinase Ia in Sp cells 
A 200 ml suspension culture of Sf9 cells was seeded with 3 x lo5 
cells/ml and grown to a cell density of 2 x lo6 cells/ml. Subsequently 
the cells were collected by centrifugation at 300 x g at 27°C and resus- 
pended in fresh medium to a final volume of 10 ml. 5 ml of this cell 
suspension were infected with recombinant baculovirus at a MO1 of 
1 for one hour at room temperature and 5 ml left uninfected as a 
control. Then the infected and the uninfected cells were each added 
to fresh medium to obtain two 100 ml suspension cultures. 
The following procedures were carried out at 4°C. At various time 
points p.i., 5 ml aliquots of the cultures were harvested by centrifuga- 
tion at 300 x g. Culture supematants were stored at -30°C until use. 
Cells were washed twice in phosphate-buffered saline, resuspended in 
0.25 ml of buffer A (20 mM Tris-HCl, pH 7.4, 5 mM EDTA, 5 mM 
dithiothreit, 5 mM benzamidine and 2 mM aminoethylbenzenesulfo- 
nylfluoride) lysed by freeze/thawing and homogenized with a teflon- 
coated glass homogenizer. Centrifugation at 18,000 x g yielded the 
soluble cell extract and the insoluble cell debris. Cell extracts were 
made up 40% (w/v) in glycerol in a final volume of 0.5 ml. The 
insoluble material was washed twice with buffer A and was then 
solubilized in 0.5 ml of buffer A + 1.25% SDS. Both preparations were 
stored at -80°C until use. 
2.4. Enzyme assays 
Equilibrium binding of [‘H]cGMP was performed according to [18] 
at 4°C. The binding to the high affinity site was determined 1 min after 
the addition of 1 mM unlabeled cGMP. The cGMP binding capacity 
of cell extracts was determined in the presence of 0.7 PM [‘H]cGMP 
and 0.1 ,uM CAMP. Phosphotransferase activity was measured as 
described in [8,18] at 30°C in the presence of 2 PM protein kinase 
inhibitor peptide (amino acids 5-24), 40 PM substrate peptide 
(GRTGRRNSI) and 10 PM cGMP. 
The amount of functional cGMP kinase Ia in St9 cell extracts was 
calculated by using the binding capacity and specific phosphotrans- 
ferase activity of purified bovine lung cGMP kinase determined al- 
ways in the same assay. Almost the same expression levels of the 
recombinant enzyme were estimated by cGMP binding and 
phosphotransferase assays. Mean values are indicated in the text. 
2.5. Protein analysis methods 
Protein concentrations of samples were measured by the method of 
Bradford [19] with bovine serum albumin as a standard. SDS-PAGE 
was carried out according to Laemmli [20] using 9% acrylamide. Gels 
were stained with Coomassie blue R-250 or transferred onto an Immo- 
bilon-P membrane (Millipore) and probed with an anti-cGMP kinase 
antibody, raised against he carboxy-terminus of the enzyme [9]. Den- 
sitometric evaluation of Coomassie-stained gels was performed using 
a LKB Ultroscan XL laser densitometer. 
3. RESULTS 
3.1. Construction and pur$cation of the recombinant 
baculovirus 
To express cGMP kinase Ia in insect cells using a 
recombinant baculovirus, initially a cDNA fragment 
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encoding bovine cGMP kinase Ia was inserted into the 
baculovirus transfer vector pVL1393. The recombinant 
transfer vector pVL1393/acgk contained the 2013 nt 
coding sequence properly orientated to allow transcrip- 
tion from the strong polyhedrin promotor. Two factors 
which may be important for an effective translation of 
a non-fused cloned gene [12] are: (a) a short upstream 
leader region which provides a suitable translation initi- 
ation context; and (b) an out-of-frame placement of the 
ATG start codon of the cloned gene with the mutated 
polyhedrin initiation codon (ATT), where some transla- 
tion may still initiate. Both these criteria were met by 
the construct. Furthermore, unwanted translation into 
the cGMP kinase coding sequence was hindered by an 
early stop codon in the polyhedrin reading frame. 
The recombinant transfer plasmid and modified 
baculovirus DNA containing a lethal deletion, which 
could only be complemented by plasmid encoded se- 
quences, were cotransfected into St9 cells. Three virus 
plaques were isolated and used to infect St9 cells. As 
analyzed by immunoblotting, cGMP binding and 
phosphotransferase assays, each independently purified 
virus efficiently directed the expression of functional 
cGMP kinase Ia in St9 cells, but to a varying extent of 
2-10% of the total cell extract protein. Culture superna- 
tants contained only a minor fraction of the total enzy- 
matic activity, possibly due to cell lysis (not shown). 
Endogenous cGMP kinase activity could not be de- 
tected in cell extracts of uninfected St9 cells using the 
same low protein concentration (but see below). The 
determination of the expressed cGMP kinase was not 
affected by the presence of an endogenous CAMP kinase 
[21]. The binding assay contained 0.1 ,uM CAMP to 
block binding of cGMP to the CAMP kinase. The 
CAMP kinase activity was blocked by the inhibitor pep- 
tide from the heat-stable inhibitor protein. For further 
experiments the recombinant virus isolate, which 
showed the highest level of cGMP Ia expression, was 
selected. 
3.2. Expression of recombinant cGMP kinase la in Sfs 
cells 
The time course of cGMP kinase Ia production in a 
recombinant culture of St9 cells infected with purified 
recombinant baculovirus is shown in Fig. 1. After infec- 
tion (MO1 = 1) cell growth and cell viability decreased 
rapidly compared to an uninfected control culture (Fig. 
1A). As estimated from the cGMP-binding capacity and 
cGMP-dependent kinase activity of cell extracts (Fig. 
lA), functional cGMP kinase Ia began to accumulate 
in infected St9 cells about 24 h p.i. A sharp optimum 
was reached at 71 h p.i. yielding 18 mg enzyme per liter 
culture or per 2.5 x lo9 cells. This represented about 
10% of the total cell extract protein. Immunoblot anal- 
ysis of soluble and insoluble cell protein revealed the 
same time course of expression (Fig. 1B). An im- 
munoreactive 75 kDa species, which co-migrated with 
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Fig. 1. Time course of cGMP kinase Ia expression in a suspension culture of Sf9 cells. (A) Growth of an uninfected (A) and an infected (0) culture 
(viable cells) and production of functional cGMP kinase Ia in infected cells (m). The kinase concentration was calculated from the cGMP binding 
capacity and phosphotransferase activity using 4 ,ug and 0.25 pg cell extract protein, respectively. (B) Immunoblot of soluble (S) and insoluble cell 
protein (I) from the same infected culture as in (A). cGK, bovine lung cGMP kinase; c, soluble and insoluble fraction from uninfected cells. (C) 
Coomassie stain of soluble (S) and insoluble (I) cell fractions prepared 71 h p.i. from virus infected (v) and uninfected control cells (c) and of the 
native enzyme (cGK). The amount of protein loaded on gels for immunoblotting and Coomassie-staining was: 1.0 pg and 20 pg of soluble cell 
extract protein, the same fraction by volume of the corresponding insoluble cell protein and 80 ng and 2.0 pug of the purified bovine lung enzyme. 
The arrow shows the position of the 75 kDa cGMP kinase subunit. 
native cGMP kinase I&, was specifically synthesized in 
infected St9 cells. At the maximal expression level 71 h 
p.i. the recombinant cGMP kinase Ia was mainly pres- 
ent in the soluble cell extract. At 36 h p.i. proteolytic 
breakdown products and enzyme associated with the 
insoluble cell fraction could also be detected. At longer 
infection times (96 and 157 h p.i.) the soluble 75 kDa 
enzyme was fully degraded and the amount of insoluble 
enzyme protein increased. These findings together with 
massive cell lysis were consistent with the rapid decrease 
of functional cGMP kinase found in St9 cells beyond 
71 h p.i. (Fig. 1A). 
At the expression optimum the recombinant enzyme 
represented one major protein of infected St9 cells as 
demonstrated by the Coomassie-stained protein gel in 
Fig. 1C. A densitometric scan indicated that the recom- 
binant cGMP kinase I& constituted approximately 10% 
of the total soluble cell protein. The Coomassie stain 
may overestimate the expression level of the recombi- 
nant cGMP kinase since a protein with a slightly higher 
mobility was present in the extracts of non-transfected 
cells. However, an expression level of 10% of the total 
soluble cell protein was also calculated from the func- 
tional assays (see above) suggesting that the correct 
value for the expression level of the cGMP kinase was 
not to far off from those values calculated by three 
different determination methods. About 10% of the ex- 
pressed enzyme were associated with the particulate cell 
fraction. Another highly expressed protein with an ap- 
parent molecular mass of 58 kDa was not recognized by 
the anti-cGMP kinase ,antibody suggesting that it was 
either an amino-terminal degradation product of the 
recombinant enzyme or a baculovirus encoded gene 
product. The latter case was most likely because a pro- 
tein with a similar apparent molecular mass not related 
to the cloned gene was already described in baculovirus 
infected Sf9 cells [21]. 
Equivalent amounts of protein from uninfected St9 
cells showed no immunoreactivity (Fig. 1B) and 
Coomassie-stainable overexpressed proteins (Fig. 1C). 
However, Sl9 cells possess a very low concentration of 
endogenous immunoreactive cGMP kinase activity, 
which could only be detected using large amounts of cell 
protein. During the whole time course of expression the 
level of endogenous cGMP kinase in uninfected St9 cells 
was about 0.03% of the total cell extract protein (not 
shown). In infected Sl9 cells the amount of endogenous 
cGMP kinase may even be lower since the viral infec- 
tion results in a shut-off of host gene expression [12]. 
Thus, at the optimal expression level of the recombinant 
cGMP kinase Ia (10%) the endogenous enzyme present 
in the preparation constituted maximally 0.3% of total 
cGMP kinase and therefore was not expected to inter- 
fere with the further characterization of the recombi- 
nant cGMP-kinase Ia. 
Monolayer cultures of infected St9 cells showed es- 
sentially the same expression pattern of recombinant 
cGMP-kinase ICC as described above for suspension cul- 
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Fig. 2. Enzymological characterization of recombinant cGMP kinase Ia. (A) Equilibrium binding of cGMP to the recombinant (upper panel, 
2.5 pg soluble cell extract protein per tube) and the native (lower panel, 0.2 pg protein per tube) cGMP kinase Id. Scatchard plots for the binding 
of cGMP to the high afIinity (triangles) and low afIinity site (squares) are shown. (B) cGMP-dependent phosphotransferase activity of the 
recombinant (0,250 ng soluble cell extract protein per tube) and the native (0, 15 ng protein per tube) cGMP kinase Ia. Cell extracts of infected 
St9 cells were prepared 71 h pi. 
tures, with an optimal expression level reaching 10% of 
the total cell extract protein at 71 h pi. However, due 
to the lower cell densities obtained in monolayer cul- 
tures the maximal amount of recombinant enzyme 
reached only 4 mg/l culture or 5 x 10’ cells (not shown). 
3.3. Characterization of recombinant cGMP-kinase Ia 
39 cell extracts prepared 71 h p.i. were used to char- 
acterize the cGMP binding sites and the phosphotrans- 
ferase activity of the expressed enzyme. All experiments 
included samples with the purified native bovine lung 
enzyme (Fig. 2). The recombinant cGMP-kinase Ia 
bound cGMP to the low and high affinity sites with 
apparent Kd values of 73 nM and 7 nM, respectively 
(Fig. 2A, upper panel). These values are nearly identical 
to those obtained with the native enzyme, which were 
73 nM and 9 nM (Fig. 2A lower panel). The activity of 
the recombinant enzyme was stimulated 1 l-fold by 
cGMP with apparent K, and V,,, values of 41 nM and 
0.3 ~mol/min and mg cell extract protein, respectively 
(Fig. 2B). In the same experiment, the native enzyme 
was stimulated g-fold by cGMP with apparent K, and 
V,, values of 48 nM and 3.2 ~mol/min and mg protein, 
respectively (Fig. 2B). These data indicate, that the 
cGMP binding sites and catalytic properties of the re- 
combinant and native cGMP-kinase Ia resemble each 
other and that the recombinant enzyme is fully biologi- 
cally active. The kinetic values of the recombinant bacu- 
lovirus enzyme are not significantly distinct from that 
of the cGMP kinase Ia expressed in mammalian cell 
lines [8,9]. 
4. DISCUSSION 
As part of our effort to elucidate the physiological 
role, biochemistry and structure of cGMP kinase, we 
report here the high-level expression of the bovine type 
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Ia isozyme using the baculovirus/insect ell system. The 
identity of the protein expressed in St9 cells infected 
with the recombinant baculovirus with cGMP kinase Ia 
was established by four criteria: (a) in SDS poly- 
acrylamide gels, the newly synthesized protein comi- 
grated with authentic cGMP-kinase Ia to an apparent 
molecular mass of 75 kDa; (b) the newly synthesized 
protein was detected by an antibody specifically di- 
rected against the carboxy-terminus of cGMP kinase; 
(c) the cell extracts of infected cells had a high density 
of cGMP specific binding sites; and (d) cGMP-depend- 
ent kinase activity indicating that the expressed enzyme 
was also enzymatically active. 
Production of the recombinant cGMP kinase Ia in 
infected St9 cells was time-dependent and the time 
course of enzyme activity correlated well with the ap- 
pearance of different immunoreactive protein species. 
The synthesized enzyme was located intracellularly, at 
the beginning mainly in the soluble cell fraction. After 
longer infection times proteolysis and a tendency of 
aggregation or association with particulate cell material 
became evident. In infected cells soluble and functional 
cGMP kinase Ia accumulated to constitute a major cell 
protein. Up to 18 mg/l culture corresponding to 10% of 
the total soluble St9 cell protein could be detected. The 
same value was obtained when the calculation was 
based on the protein stain, the binding capacity or ki- 
nase activity. This expression level is above average 
when compared to that of other serine/threonine protein 
kinases expressed as non-fusion proteins in insect cells 
[13-l 51. The high expression may be attributable in part 
to the construction of the transfer vector. 
The apparent molecular mass, immunoreactivity and 
functional characteristics such as the Kd values for 
cGMP binding sites or the K, value for phosphotrans- 
ferase activity of the recombinant cGMP kinase Ia were 
indistinguishable from the native enzyme. These find- 
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ings suggest hat Sf9 insect cells are capable of express- 
ing correctly folded and presumably post-translation- 
ally modified cGMP kinase Ia, which is equivalent to 
the protein synthesized in mammalian cells. The en- 
dogenous cGMP kinase activity maximally represented 
0.3% of the total cGMP-kinase present in baculovirus 
infected cells at the expression optimum. Thus it should 
not have interfered with the characterization of the fully 
active recombinant enzyme. 
In conclusion, through the establishment of the bacu- 
lovirus expression system, large quantities of biologi- 
cally active cGMP-kinase Ia could be provided, over- 
coming the problems inherent in mammalian and bacte- 
rial expression methods. This expression system should 
also be an useful tool to produce mutant forms of 
cGMP-kinase and will facilitate detailed biochemical 
and structure-function studies on cGMP kinase. 
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